| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:543206402:3199 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:543206402:3199?format=raw |
LEADER: 03199fam a2200421 a 4500
001 3980357
005 20221027013017.0
008 930610t19941994flua b 101 0 eng c
010 $a 93025610
020 $a0849383919
035 $a(OCoLC)28346088
035 $a(OCoLC)ocm28346088
035 $9AHW4931HS
035 $a(NNC)3980357
035 $a3980357
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRC382$b.N66 1994
060 00 $aWL 359 N822 1994
082 00 $a616.8/33/07$220
245 00 $aNoradrenergic mechanisms in Parkinson's disease /$cedited by M. Briley, M. Marien.
260 $aBoca Raton, Fla. :$bCRC Press,$c[1994], ©1994.
300 $a267 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aPierre Fabre monographs
504 $aIncludes bibliographical references and index.
505 0 $a1. Defining idiopathic Parkinson's disease / J. M. Gybels -- 2. The validity of the MPTP primate model for the neurochemical pathology of idiopathic Parkinson's disease / O. Hornykiewicz and C. Pifl -- 3. Recovery from MPTP-induced parkinsonian manifestations following locus coeruleus lesions in squirrel monkeys / M. Mavridis, A. Degryse, A. Lategan, M. Marien and F. Colpaert -- 4. The possible role of noradrenergic deficits in selected signs of Parkinson's disease / M. Gerlach, K. Jellinger and P. Riederer -- 5. Anatomy of the noradrenergic pathways in the primate brain: alterations in Parkinson's disease / P. Gaspar -- 6. The locus coeruleus in Parkinson's disease / R. Raisman-Vozari -- 7. Interactions between noradrenaline and dopamine neurotransmission in the rat prefrontal cortex and their consequences on dopaminergic subcortical function / J. P. Tassin, F. Trovero, G. Blanc, D. Herve and J. Glowinski -- 8. Norepinephrine-dopamine interactions: one step beyond / S. M. Antelman and A. R. Caggiula.
505 0 $a9. Noradrenergic control of striatal dopamine release / M. Marien, A. Lategan and F. Colpaert -- 10. The effects of [actual symbol not reproducible] antagonists on extracellular dopamine concentrations in rat striatum / D. Nutt, M. Lalies and A. Hudson -- 11. Glial cells as targets of the central noradrenergic system. An update / E. A. Stone -- 12. Adrenergic activation of phospholipase C in striatal astrocytes: neurotransmitter interactions / M. El-Etr -- 13. Noradrenergic control of gap junction permeability in cultured striatal astrocytes / C. Giaume -- 14. Noradrenergic mechanisms in Parkinson's disease: a theory / F. C. Colpaert.
650 0 $aParkinson's disease$xPathophysiology$vCongresses.
650 0 $aNoradrenergic mechanisms$vCongresses.
650 2 $aParkinson Disease$xphysiopathology.$0https://id.nlm.nih.gov/mesh/D010300Q000503
650 2 $aNorepinephrine$xphysiology.$0https://id.nlm.nih.gov/mesh/D009638Q000502
650 2 $aLocus Coeruleus$xphysiology.$0https://id.nlm.nih.gov/mesh/D008125Q000502
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aBriley, M.
700 1 $aMarien, M.
830 0 $aPierre Fabre monographs.$0http://id.loc.gov/authorities/names/n88525429
852 00 $boff,hsl$hRC382$i.N66 1994